"Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis

被引:83
作者
Yonezu, Tadahiro [1 ]
Ito, Shoichi [1 ]
Mori, Masahiro [1 ]
Ogawa, Yoshitsugu [2 ]
Makino, Takahiro [3 ]
Uzawa, Akiyuki [1 ]
Kuwabara, Satoshi [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba 2608677, Japan
[2] Chiba Cardiovasc Ctr, Dept Neurol, Chiba, Japan
[3] Kashima Rosai Hosp, Dept Neurol, Ibaraki, Japan
关键词
multiple sclerosis; spinal cord; spotty; Neuromyelitis optica; bright; MRI; neuroimaging; INTERFERON; AQUAPORIN-4; NATALIZUMAB; DISTINCTION; THERAPY; MARKER;
D O I
10.1177/1352458513495581
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Spinal magnetic resonance imaging (MRI) finding of longitudinally extensive spinal cord lesions (LESCL) extending over three vertebral segments and involvements of spinal central gray matter have been reported in patients with neuromyelitis optica (NMO). Objectives: We aimed to review spinal MRI findings in NMO and multiple sclerosis (MS), and to determine whether the "bright spotty lesions" (BSLs) are a discriminative finding of NMO. Methods: For this study, 24 consecutive patients with NMO and 34 patients with MS were enrolled. BSLs were defined as very hyperintense spotty lesions on axial T2WI. We also studied the length, distribution, signal homogeneity, size, and presence of contrast-enhanced lesions. Results: BSLs were more frequently found in patients with NMO (54%) than in those with MS (3%; p < 0.01). LESCL were found in 67% of the NMO patients. BSLs were seen in 63% of the patients without LESCL. BSLs or LESCL were found in 88% of the NMO patients. Inhomogeneous lesions, transversally extensive lesions, and central lesions were more frequently seen in NMO than in MS. Conclusions: BSLs are a newly defined spinal MRI finding specifically seen in NMO. In combination with LESCL, BSLs can help differentiate patients with NMO from those with MS with higher sensitivity than LESCL alone.
引用
收藏
页码:331 / 337
页数:7
相关论文
共 20 条
  • [1] Conventional brain MRI in neuromyelitis optica
    Cabrera-Gomez, J. A.
    Kister, I.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (06) : 812 - 819
  • [2] Brain magnetic resonance imaging findings in relapsing neuromyelitis optica
    Cabrera-Gomez, Jose A.
    Quevedo-Sotolongo, L.
    Gonzalez-Quevedo, A.
    Lima, S.
    Real-Gonzalez, Y.
    Cristofol-Corominas, M.
    Romero-Garcia, K.
    Ugarte-Sanchez, C.
    Jordan-Gonzalez, J.
    Gonzalez de la Nuez, J. E.
    Garcia Lahera, J.
    Tellez, R.
    Pedroso-Ibanez, I.
    Rodriguez Roca, R.
    Cabrera-Nunez, A. Y.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 (02): : 186 - 192
  • [3] Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay
    Hayakawa, Sei
    Mori, Masahiro
    Okuta, Akiko
    Kamegawa, Akiko
    Fujiyoshi, Yoshinori
    Yoshiyama, Yasumasa
    Mitsuoka, Kaoru
    Ishibashi, Kenichi
    Sasaki, Sei
    Hattori, Takamichi
    Kuwabara, Satoshi
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2008, 196 (1-2) : 181 - 187
  • [4] "Cloud-like Enhancement" Is a Magnetic Resonance Imaging Abnormality Specific to Neuromyelitis Optica
    Ito, Shoichi
    Mori, Masahiro
    Makino, Takahiro
    Hayakawa, Sei
    Kuwabara, Satoshi
    [J]. ANNALS OF NEUROLOGY, 2009, 66 (03) : 425 - 428
  • [5] DOES NATALIZUMAB THERAPY WORSEN NEUROMYELITIS OPTICA?
    Jacob, Anu
    Hutchinson, Michael
    Elsone, Liene
    Kelly, Siobhan
    Ali, Rehiana
    Saukans, Ivars
    Tubridy, Niall
    Boggild, Mike
    [J]. NEUROLOGY, 2012, 79 (10) : 1065 - 1066
  • [6] Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
    Kleiter, Ingo
    Hellwig, Kerstin
    Berthele, Achim
    Kuempfel, Tania
    Linker, Ralf A.
    Hartung, Hans-Peter
    Paul, Friedemann
    Aktas, Orhan
    [J]. ARCHIVES OF NEUROLOGY, 2012, 69 (02) : 239 - 245
  • [7] Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study
    Krampla, Wolfgang
    Aboul-Enein, Fahmy
    Jecel, Julia
    Lang, Wilfried
    Fertl, Elisabeth
    Hruby, Walter
    Kristoferitsch, Wolfgang
    [J]. EUROPEAN RADIOLOGY, 2009, 19 (10) : 2535 - 2543
  • [8] A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
    Lennon, VA
    Wingerchuk, DM
    Kryzer, TJ
    Pittock, SJ
    Lucchinetti, CF
    Fujihara, K
    Nakashima, I
    Weinshenker, BG
    [J]. LANCET, 2004, 364 (9451) : 2106 - 2112
  • [9] IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
    Lennon, VA
    Kryzer, TJ
    Pittock, SJ
    Verkman, AS
    Hinson, SR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (04) : 473 - 477
  • [10] Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
    Min, Ju-Hong
    Kim, Byoung Joon
    Lee, Kwang Ho
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (01) : 113 - 115